Vireo Health, a Subsidiary of Goodness Growth Holdings to Launch Whole Flower Cannabis Products
Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF), a company engaged in cultivating, producing, and selling medical cannabis, announced that Vireo Health of New York, a subsidiary wholly owned by it, will launch the sale of whole flower cannabis.
The product ‘whole flower’, which is the bud of the cannabis plant, will be available at three of the company’s four dispensaries in New York from October 30. These three are the dispensaries located in Queens, White Plains, and Albany.
Vireo Health is one of the ten companies that have the license to cultivate and sell cannabis in New York. The product will also be home delivered to the customers in the New York City metro area. At the company’s Binghamton dispensary, whole flower will be available from November 1.
Also Read: Jushi Holdings Announces a Senior Secured Credit Facility worth US$100 million from SunStream Bancorp
About Goodness Growth Holdings, Inc.
Goodness Growth Holdings is a science-focused cannabis company, cultivating and producing and marketing pharmaceutical-grade cannabis products. The company manages its subsidiary Vireo Health, Inc., a multi-state cannabis company, and Resurgent Biosciences, another subsidiary focused on clinical research of cannabis medicines, as well as research and development of intellectual properties.
Its branded cannabis products are grown in its eco-friendly, state-of-the-art cultivation facilities and are marketed through a wide network of retail locations, and cannabis dispensaries of other companies.
The company is licensed to cultivate, process, and market cannabis in eight markets, and runs 18 dispensaries across the United States. Goodness Growth Holdings trades on the CSE under the stock symbol GDNS and on the OTCQX under the stock symbol GDNSF.
Vireo Health’s Whole Flower Cannabis Products
Vireo Health will offer many new strains as whole flower cannabis, the first of them being OG Kush. The strains are cultivated and produced at the company’s indoor facility. Five more strains are expected to be in the market by the end of the year 2021.
Goodness Growth Chairman and Chief Executive Officer Kyle Kingsley was all praise for the Cannabis Control Board & Office of Cannabis Management for taking speedy action to improve the medical cannabis program by consenting to the idea of whole flower products.
He said that the company was excited to market its premium whole flower products and thereby help to make cannabis more easily accessible and affordable to the existing as well as new patients of New York.
Also Read: HEXO Posts the Departure of its CEO and Co-Founder Sebastien St-Louis
Dr. Kingsley expressed his gratitude to the Cannabis Control Board & Office of Cannabis Management because, by the beginning of October, they had given permission to cannabis dispensaries to sell whole flower cannabis products to patients who were in need of it. The new rule allowed patients to purchase and store enough supply for sixty days’ requirement.
Dr. Kingsley added that since whole flower products were more affordable, patients, who were switching to these products from the other forms in which they were using it, were likely to get about 50% reduction in costs.
The reduced price as well as the availability of different strains of cannabis to choose from, gave wider option for patients. According to Dr. Kingsly, it was an important step in the evolution of New York’s cannabis market.
Vireo’s first whole flower strain, OG Kush, will be available to customers from October 30. All its whole flower products will be available in packs of 3.5 grams and 7 grams. And more strains are expected to be in the market throughout the months of November and December. Like all the earlier products of the company in New York, whole flower products will also be Kosher Certified.
Leave a Reply